Identifying functional modules for coronary artery disease by a prior knowledge-based approach.

Until recently, the underlying genetic mechanisms for coronary artery disease (CAD) have been largely unknown, with just a list of genes identified accounting for very little of the disease in the population. Hence, a systematic dissection of the sophisticated interplays between these individual disease genes and their functional involvements becomes essential. Here, we presented a novel knowledge-based approach to identify the functional modules for CAD. First, we selected 266 disease genes in CADgene database as the initial seed genes, and used PPI knowledge as a guide to expand these genes into a CAD-specific gene network. Then, we used Newman's algorithm to decompose the primary network into 14 compact modules with high modularity. By analysis of these modules, we further identified 114 hub genes, all either directly or indirectly associated with CAD. Finally, by functional analysis of these modules, we revealed several novel pathogenic mechanisms for CAD (for examples, some yet rarely concerned like peptide YY receptor activity, Fc gamma R-mediated phagocytosis and actin cytoskeleton regulation etc.).

[1]  Hui Liu,et al.  CADgene: a comprehensive database for coronary artery disease genes , 2010, Nucleic Acids Res..

[2]  Jing Zhu,et al.  Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network , 2007, Bioinform..

[3]  S. Tyagi Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. , 1999, Clinical and experimental hypertension.

[4]  Eric J. Topol,et al.  Scientific and therapeutic advances in antiplatelet therapy , 2003, Nature Reviews Drug Discovery.

[5]  Rachael J. Oakenfull,et al.  Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent , 2012, Hypertension Research.

[6]  R. Ravi,et al.  A nearly best-possible approximation algorithm for node-weighted Steiner trees , 1993, IPCO.

[7]  D. Erlinge,et al.  Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP , 1994, Regulatory Peptides.

[8]  R. Colman,et al.  Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions. , 2004, Molecular immunology.

[9]  A. von Eckardstein,et al.  Androgens and coronary artery disease. , 2003, Endocrine reviews.

[10]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[11]  L. Khachigian,et al.  Sp1, acetylated histone‐3 and p300 regulate TRAIL transcription: Mechanisms of PDGF‐BB‐mediated VSMC proliferation and migration , 2012, Journal of cellular biochemistry.

[12]  G. Rosano,et al.  Acute anti-ischemic effect of testosterone in men with coronary artery disease. , 1999, Circulation.

[13]  Yun Xiao,et al.  Cell cycle-dependent gene networks relevant to cancer , 2008 .

[14]  Akira Kawamura,et al.  High Density Lipoprotein–Induced Angiogenesis Requires the Activation of Ras/MAP Kinase in Human Coronary Artery Endothelial Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Satoh,et al.  Role of Toll like receptor signaling pathway in ischemic coronary artery disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[16]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[17]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[18]  U. Alon Biological Networks: The Tinkerer as an Engineer , 2003, Science.

[19]  Antoine M. van Oijen,et al.  Real-time single-molecule observation of rolling-circle DNA replication , 2009, Nucleic acids research.

[20]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[21]  E. Lakatta,et al.  Calpain-1 Regulation of Matrix Metalloproteinase 2 Activity in Vascular Smooth Muscle Cells Facilitates Age-Associated Aortic Wall Calcification and Fibrosis , 2012, Hypertension.

[22]  M E J Newman,et al.  Modularity and community structure in networks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Boumpas,et al.  Toll like receptors and autoimmunity: a critical appraisal. , 2007, Journal of autoimmunity.

[24]  P. Davies,et al.  Quantitative studies of endothelial cell adhesion. Directional remodeling of focal adhesion sites in response to flow forces. , 1994, The Journal of clinical investigation.

[25]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[26]  K. Fujiwara,et al.  Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[27]  Thiennu H. Vu,et al.  Thrombin receptor expression in normal and atherosclerotic human arteries. , 1992, The Journal of clinical investigation.

[28]  M. Hsieh,et al.  Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences. , 2012, Rheumatology.

[29]  Albert-László Barabási,et al.  Statistical mechanics of complex networks , 2001, ArXiv.

[30]  Steven M. Holland,et al.  Coronary Artery Abnormalities in Hyper-IgE Syndrome , 2011, Journal of Clinical Immunology.

[31]  G. Reaven Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[32]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[33]  Xing-Ming Zhao,et al.  Identifying disease genes and module biomarkers by differential interactions , 2012, J. Am. Medical Informatics Assoc..

[34]  T. Hansen,et al.  Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver Disease , 2011, PloS one.

[35]  J. Barrett,et al.  CCAAT/enhancer binding protein α, β and δ gene variants: associations with obesity related phenotypes in the Leeds Family Study , 2010, Diabetes & vascular disease research.

[36]  J. Egido,et al.  NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. , 2004, Stroke.

[37]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[38]  V. Khode,et al.  Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study , 2012, Journal of cardiovascular disease research.

[39]  H. Rakugi,et al.  Influence of renin angiotensin system gene polymorphisms on visit-to-visit blood pressure variability in hypertensive patients. , 2012, American journal of hypertension.

[40]  Simon C. Potter,et al.  Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease , 2011, PLoS genetics.

[41]  H. Arnqvist,et al.  Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells , 2005, Diabetologia.

[42]  N. Kalinina,et al.  Smad Expression in Human Atherosclerotic Lesions Evidence for Impaired TGF-β/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[43]  K. Safranow,et al.  Association of glucocorticoid receptor gene NR3C1 genetic variants with angiographically documented coronary artery disease and its risk factors. , 2013, Archives of medical research.

[44]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[45]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[46]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[47]  Jing Zhu,et al.  Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network , 2007, Bioinform..

[48]  M. Bennett,et al.  DNA damage, p53, apoptosis and vascular disease. , 2007, Mutation research.

[49]  Zhongming Zhao,et al.  GenRev: exploring functional relevance of genes in molecular networks. , 2012, Genomics.

[50]  D E Ingber,et al.  Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. , 1994, Biophysical journal.

[51]  Mark E. J. Newman,et al.  Power-Law Distributions in Empirical Data , 2007, SIAM Rev..

[52]  Yves Deville,et al.  Relevant subgraph extraction from random walks in a graph , 2006 .

[53]  E. Lonn,et al.  The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. , 2001, The American journal of cardiology.

[54]  Serban Nacu,et al.  Gene expression network analysis and applications to immunology , 2007, Bioinform..

[55]  John Guare,et al.  Six Degrees of Separation: A Play , 1990 .

[56]  M. Khoury,et al.  Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. , 2006, American journal of epidemiology.

[57]  Tobias Müller,et al.  Bioinformatics Applications Note Systems Biology Bionet: an R-package for the Functional Analysis of Biological Networks , 2022 .

[58]  A. Tedgui,et al.  The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives , 2002, Current opinion in lipidology.

[59]  D. Spandidos,et al.  Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. , 2007, Thrombosis research.

[60]  H. Kaneto,et al.  Role of Pim-1 in Smooth Muscle Cell Proliferation* , 2004, Journal of Biological Chemistry.

[61]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[62]  Cheng-Yan Kao,et al.  Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression , 2011, BMC Bioinformatics.

[63]  W. T. Chen,et al.  Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. , 1998, Circulation research.